Cargando…
Indeterminate thyroid nodules in the era of molecular genomics
BACKGROUND: Indeterminate thyroid nodules are diagnosed in up to 30% of fine‐needle aspirations and the risk of malignancy in these cases are highly variable. Consequently, managing these nodules has been a challenge. While a diagnostic thyroidectomy would help clarify the pathology, there is the ri...
Autores principales: | Rao, Sarika N., Bernet, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503096/ https://www.ncbi.nlm.nih.gov/pubmed/32436637 http://dx.doi.org/10.1002/mgg3.1288 |
Ejemplares similares
-
Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2019) -
Local molecular analysis of indeterminate thyroid nodules
por: Gill, Mandeep S., et al.
Publicado: (2015) -
Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer
por: Ali, Syed Z., et al.
Publicado: (2019) -
Multiplatform molecular test performance in indeterminate thyroid nodules
por: Lupo, Mark A., et al.
Publicado: (2020) -
Critical analysis of molecular tests in indeterminate thyroid nodules
por: Danilovic, Debora L. S., et al.
Publicado: (2018)